Carelabs to Absorb Wholly Owned Subsidiary Babitalk
Carelabs will absorb its wholly owned beauty-care platform subsidiary Babitalk, with the merger scheduled to take effect Dec. 18, 2026. Babitalk will dissolve, with its assets, rights, obligations and employees transferring to the surviving company. No new shares will be issued; the merger will leave the largest shareholder unchanged. The transaction aims to improve management efficiency and strengthen business competitiveness. The merger will not affect consolidated financial position or earnings because Babitalk is already consolidated. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carelabs Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261015000118), on October 15, 2026, and is solely responsible for the information contained therein. (C)
Story updates
Carelabs will absorb its wholly owned beauty-care platform subsidiary Babitalk, with the merger scheduled to take effect Dec. 18, 2026. Babitalk will dissolve, with its assets, rights, obligations and employees transferring to the surviving company. No new shares will be issued; the merger will leave the largest shareholder unchanged.
The transaction aims to improve management efficiency and strengthen business competitiveness. The merger will not affect consolidated financial position or earnings because Babitalk is already consolidated. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice.
Carelabs Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261015000118), on October 15, 2026, and is solely responsible for the information contained therein.
(C)